RMD
NYSE · Health Care
Resmed Inc
$235.38
+0.08 (+0.03%)
Financial Highlights (FY 2026)
Revenue
5.43B
Net Income
1.46B
Gross Margin
61.1%
Profit Margin
26.9%
Rev Growth
+10.2%
D/E Ratio
0.10
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 61.1% | 61.1% | 29.6% | 29.6% |
| Operating Margin | 33.4% | 30.0% | 7.2% | 6.1% |
| Profit Margin | 26.9% | 25.6% | 6.1% | 6.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 5.43B | 4.93B | 19.88B | 18.80B |
| Gross Profit | 3.32B | 3.01B | 5.89B | 5.57B |
| Operating Income | 1.81B | 1.48B | 1.43B | 1.14B |
| Net Income | 1.46B | 1.19B | 1.22B | 1.24B |
| Gross Margin | 61.1% | 61.1% | 29.6% | 29.6% |
| Operating Margin | 33.4% | 30.0% | 7.2% | 6.1% |
| Profit Margin | 26.9% | 25.6% | 6.1% | 6.6% |
| Rev Growth | +10.2% | +10.2% | -5.8% | +13.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 1.50B | 1.50B | 17.00B | 16.78B |
| Total Equity | 15.00B | 15.00B | 22.02B | 19.96B |
| D/E Ratio | 0.10 | 0.10 | 0.77 | 0.84 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.86B | 1.60B | 1.93B | 1.63B |
| Free Cash Flow | — | — | 977.26M | 1.00B |